![](/img/cover-not-exists.png)
“Prophylactic” adefovir “add on” is associated with a lower rate of virologic breakthrough in patients with optimal response to lamivudine and undetectable HBV–DNA
M. Puoti, F. Zacchi, S. Zaltron, A. Spinetti, S. Rossi, K. Prestini, M. Mendeni L. Biasi, G. CarosiVolume:
40
Year:
2008
Language:
english
DOI:
10.1016/j.dld.2007.12.090
File:
PDF, 70 KB
english, 2008